Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
1. : Drugs in cardiology / edited by Ephraim Donoso
| 1. : Drugs in cardiology / edited by Ephraim Donoso |
| Pubbl/distr/stampa | New York [etc.], : Stratton intercontinental Medical book corporation, 1975 |
| Descrizione fisica | v. ; 24 cm |
| Disciplina | 615.71 |
| Soggetto topico | Farmaci cardiovascolari |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | <1.> : XII, 240 p. ; <2.> : VI, 194 p. : ill. |
| Record Nr. | UNISA-990002117090203316 |
| New York [etc.], : Stratton intercontinental Medical book corporation, 1975 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Advances in the Diagnosis of Coronary Atherosclerosis / / edited by Suna Kirac
| Advances in the Diagnosis of Coronary Atherosclerosis / / edited by Suna Kirac |
| Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , 2011 |
| Descrizione fisica | 1 online resource (392 pages) |
| Disciplina | 615.71 |
| Soggetto topico | Cardiovascular pharmacology |
| ISBN | 953-51-6561-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910138163203321 |
| [Place of publication not identified] : , : IntechOpen, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
American journal of cardiovascular drugs : drugs, devices and other interventions
| American journal of cardiovascular drugs : drugs, devices and other interventions |
| Pubbl/distr/stampa | [Mairangi Bay, Auckland, N.Z.], : Adis International |
| Descrizione fisica | 1 online resource (volumes) : illustrations |
| Disciplina | 615.71 |
| Soggetto topico |
Cardiovascular agents
Cardiovascular system - Diseases - Treatment Cardiovascular Agents - therapeutic use Cardiology - instrumentation Cardiovascular Diseases - therapy Heart Diseases - drug therapy Agents cardiovasculaires Appareil cardiovasculaire - Maladies - Traitement |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 1179-187X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996218571003316 |
| [Mairangi Bay, Auckland, N.Z.], : Adis International | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
American journal of cardiovascular drugs : drugs, devices and other interventions
| American journal of cardiovascular drugs : drugs, devices and other interventions |
| Pubbl/distr/stampa | [Mairangi Bay, Auckland, N.Z.], : Adis International |
| Descrizione fisica | 1 online resource (volumes) : illustrations |
| Disciplina | 615.71 |
| Soggetto topico |
Cardiovascular agents
Cardiovascular system - Diseases - Treatment Cardiovascular Agents - therapeutic use Cardiology - instrumentation Cardiovascular Diseases - therapy Heart Diseases - drug therapy Agents cardiovasculaires Appareil cardiovasculaire - Maladies - Traitement |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 1179-187X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910154543203321 |
| [Mairangi Bay, Auckland, N.Z.], : Adis International | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Angiotensin-(1-7) : A Comprehensive Review / / edited by Robson Augusto Souza Santos
| Angiotensin-(1-7) : A Comprehensive Review / / edited by Robson Augusto Souza Santos |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (244 pages) |
| Disciplina |
572.65
615.71 |
| Soggetto topico |
Cardiology
Human physiology Human Physiology |
| ISBN | 3-030-22696-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | INTRODUCTION -- 1.ANGIOTENSIN-(1-7) FORMATION AND METABOLISM -- Part I. TOOLS FOR STUDYING ANG-(1-7) -- 2. Pharmacological Tools-RAS -- 3. Genetic Models (ACE2 Models, MAS Models, Ang-(1-7) Models) -- Part II. ACTIONS OF ANGIOTENSIN-(1-7) -- 4. Brain (Ang-(1-7) Metabolism in the Brain, Ang-(1-7) Location in the Brain, MAS Location in the Brain, Ang-(1-7) Actions in the Brain, Cardiovascular Effects of Angiotensin-(1-7) at Specific Medullary Sites, Cardiovascular Effects of Angiotensin-(1-7) at Specific Hypothalamic Sites, Other Angiotensin-(1-7) Effects in the Brain, Neurotransmitter / Neuromodulator Effects of Ang-(1-7) -- 5. Heart (B1 Coronary vessels & Cardiomyocytes) -- 6. Ang-(1–7) and Cardioprotection -- 7. Blood Vessels -- 8. Kidney -- 9. Lung -- 10. Endocrine System -- 11. Skeletal Muscle System -- 12. Liver -- 13. Angiotensin-(1-7) and inflammation -- 14. J. Angiotensin-(-1-7) and Cancer -- 15. CONCLUDING REMARKS -- ACKNOWLEDGMENTS. |
| Record Nr. | UNINA-9910349549003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Basi farmacologiche della terapia cardiovascolare / Fabrizio Ledda ...[et al.]
| Basi farmacologiche della terapia cardiovascolare / Fabrizio Ledda ...[et al.] |
| Pubbl/distr/stampa | Torino : UTET, c2000 |
| Descrizione fisica | XVIII, 269 p. ; 26 cm. |
| Disciplina | 615.71 |
| Soggetto topico |
Medicinali cardiovascolari
Apparato circolatorio - Malattie - Farmacoterapia |
| ISBN | 88-02-05684-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ita |
| Record Nr. | UNISA-990000318290203316 |
| Torino : UTET, c2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
| Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen |
| Autore | Killeen Matthew J |
| Pubbl/distr/stampa | Singapore, : World Scientific Pub. Co., 2012 |
| Descrizione fisica | 1 online resource (189 p.) |
| Disciplina |
363.738/74
363.73874 615.71 |
| Soggetto topico | Cardiovascular agents |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-66922-5
9786613646156 981-4317-46-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia Variability of repolarization |
| Record Nr. | UNINA-9910451573503321 |
Killeen Matthew J
|
||
| Singapore, : World Scientific Pub. Co., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
| Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen |
| Autore | Killeen Matthew J |
| Pubbl/distr/stampa | Singapore, : World Scientific Pub. Co., 2012 |
| Descrizione fisica | 1 online resource (189 p.) |
| Disciplina |
363.738/74
363.73874 615.71 |
| Soggetto topico | Cardiovascular agents |
| ISBN |
1-280-66922-5
9786613646156 981-4317-46-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia Variability of repolarization |
| Record Nr. | UNINA-9910779277703321 |
|
Killeen Matthew J
|
||
| Singapore, : World Scientific Pub. Co., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
| Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen |
| Autore | Killeen Matthew J |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Singapore, : World Scientific Pub. Co., 2012 |
| Descrizione fisica | 1 online resource (189 p.) |
| Disciplina |
363.738/74
363.73874 615.71 |
| Soggetto topico | Cardiovascular agents |
| ISBN |
1-280-66922-5
9786613646156 981-4317-46-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia Variability of repolarization |
| Record Nr. | UNINA-9910824978503321 |
|
Killeen Matthew J
|
||
| Singapore, : World Scientific Pub. Co., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiac drugs / / editors, Kanu Chatterjee, Eric J. Topol
| Cardiac drugs / / editors, Kanu Chatterjee, Eric J. Topol |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | New Delhi, [India] : , : Jaypee, The Health Sciences Publisher, , 2015 |
| Descrizione fisica | 1 online resource (551 p.) |
| Disciplina | 615.71 |
| Soggetto topico |
Cardiovascular agents - Physiological effect
Heart - Diseases - Chemotherapy |
| Soggetto genere / forma | Electronic books. |
| ISBN | 93-86150-11-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910466220303321 |
| New Delhi, [India] : , : Jaypee, The Health Sciences Publisher, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
